Lingzhi Hu
Washington University in St. Louis
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Lingzhi Hu.
Magnetic Resonance in Medicine | 2015
Lingzhi Hu; Samuel A. Wickline; Joshua L. Hood
Exosomes are cell derived extracellular nanovesicles that relay molecular signals pertinent to both normal physiologic and disease processes. The ability to modify and track exosomes in vivo is essential to understanding exosome pathogenesis, and for utilizing exosomes as effective diagnostic and therapeutic nanocarriers to treat diseases.
The FASEB Journal | 2013
Hua Pan; Jacob W Myerson; Lingzhi Hu; Jon N. Marsh; Kirk K. Hou; Michael J. Scott; John S. Allen; Grace Hu; Susana San Roman; Gregory M. Lanza; Robert D. Schreiber; Paul H. Schlesinger; Samuel A. Wickline
The emerging demand for programmable functionalization of existing base nanocarriers necessitates development of an efficient approach for cargo loading that avoids nanoparticle redesign for each individual application. Herein, we demonstrate in vivo a postformulation strategy for lipidic nanocarrier functionalization with the use of a linker peptide, which rapidly and stably integrates cargos into lipidic membranes of nanocarriers after simple mixing through a self‐assembling process. We exemplified this strategy by generating a VCAM‐1‐targeted perfluorocarbon nanoparticle for in vivo targeting in atherosclerosis (ApoE‐deficient) and breast cancer (STAT‐1‐deficient) models. In the atherosclerotic model, a 4.1‐fold augmentation in binding to affected aortas was observed for targeted vs. nontargeted nanoparticles (P<0.0298). Likewise, in the breast cancer model, a 4.9‐fold increase in the nanoparticle signal from tumor vasculature was observed for targeted vs. nontargeted nanoparticles (P<0.0216). In each case, the nanoparticle was registered with fluorine (19F) magnetic resonance spectroscopy of the nanoparticle perfluorocarbon core, yielding a quantitative estimate of the number of tissue‐bound nanoparticles. Because other common nanocarriers with lipid coatings (e.g., liposomes, micelles, etc.) can employ this strategy, this peptide linker postformulation approach is applicable to more than half of the available nanosystems currently in clinical trials or clinical uses.—Pan, H., Myerson, J. W., Hu, L., Marsh, J. N., Hou K., Scott, M. J., Allen, J. S., Hu, G., San Roman, S., Lanza, G. M., Schreiber, R. D., Schlesinger, P. H., Wickline, S. A. Programmable nanoparticle functionalization for in vivo targeting. FASEB J. 27, 255–264 (2013). www.fasebj.org
American Journal of Physiology-heart and Circulatory Physiology | 2013
Lei Zhang; John S. Allen; Lingzhi Hu; Shelton D. Caruthers; Samuel A. Wickline; Junjie Chen
Cardiomyocyte organization is a critical determinant of coordinated cardiac contractile function. Because of the acute opening of the pulmonary circulation, the relative workload of the left ventricle (LV) and right ventricle (RV) changes substantially immediately after birth. We hypothesized that three-dimensional cardiomyocyte architecture might be required to adapt rapidly to accommodate programmed perinatal changes of cardiac function. Isolated fixed hearts from pig fetuses or pigs at midgestation, preborn, postnatal day 1 (P1), postnatal day 5, postnatal day 14 (P14), and adulthood (n = 5 for each group) were acquired for diffusion-weighted magnetic resonance imaging. Cardiomyocyte architecture was visualized by three-dimensional fiber tracking and was quantitatively evaluated by the measured helix angle (α(h)). Upon the completion of MRI, hearts were sectioned and stained with hematoxylin/eosin (H&E) to evaluate cardiomyocyte alignment, with picrosirius red to evaluate collagen content, and with anti-Ki67 to evaluate postnatal cell proliferation. The helical architecture of cardiomyocyte was observed as early as the midgestational period. Postnatal changes of cardiomyocyte architecture were observed from P1 to P14, which primary occurred in the septum and RV free wall (RVFW). In the septum, the volume ratio of LV- vs. RV-associated cardiomyocytes rapidly changed from RV-LV balanced pattern at birth to LV dominant pattern by P14. In the RVFW, subendocardial α(h) decreased by ~30° from P1 to P14. These findings indicate that the helical architecture of cardiomyocyte is developed as early as the midgestation period. Substantial and rapid adaptive changes in cardiac microarchitecture suggested considerable developmental plasticity of cardiomyocyte form and function in the postnatal period in response to altered cardiac mechanical function.
Journal of Magnetic Resonance Imaging | 2011
Lingzhi Hu; Frank D. Hockett; Junjie Chen; Lei Zhang; Shelton D. Caruthers; Gregory M. Lanza; Samuel A. Wickline
To propose and test a universal strategy for building 19F/1H dual‐frequency RF coil that permits multiple coil geometries.
Magnetic Resonance in Medicine | 2014
Lingzhi Hu; Junjie Chen; Xiaoxia Yang; Angana Senpan; John S. Allen; Noriko Yanaba; Shelton D. Caruthers; Gregory M. Lanza; Marc R. Hammerman; Samuel A. Wickline
We sought to develop a unique sensor‐reporter approach for functional kidney imaging that employs circulating perfluorocarbon nanoparticles and multinuclear 1H/19F MRI.
Magnetic Resonance in Medicine | 2013
Lingzhi Hu; Junjie Chen; Xiaoxia Yang; Shelton D. Caruthers; Gregory M. Lanza; Samuel A. Wickline
We present a novel blood flow‐enhanced‐saturation‐recovery (BESR) sequence, which allows rapid in vivo T1 measurement of blood for both 1H and 19F nuclei. BESR sequence is achieved by combining homogeneous spin preparation and time‐of‐flight image acquisition and therefore preserves high time efficiency and signal‐to‐noise ratio for 19F imaging of circulating perfluorocarbon nanoparticles comprising a perfluoro‐15‐crown‐5‐ether core and a lipid monolayer (nominal size = 250 nm). The consistency and accuracy of the BESR sequence for measuring T1 of blood was validated experimentally. With a confirmed linear response feature of 19F R1 with oxygen tension in both salt solution and blood sample, we demonstrated the feasibility of the BESR sequence to quantitatively determine the oxygen tension within mouse left and right ventricles under both normoxia and hyperoxia conditions. Thus, 19F BESR MRI of circulating perfluorocarbon nanoparticles represents a new approach to noninvasively evaluate intravascular oxygen tension. Magn Reson Med, 2013.
Journal of Magnetic Resonance Imaging | 2011
Lingzhi Hu; Lei Zhang; Junjie Chen; Gregory M. Lanza; Samuel A. Wickline
To develop a physical model for the 19F relaxation enhancement in paramagnetic perfluorocarbon nanoparticles (PFC NP) and demonstrate its application in monitoring cellular endosomal functionality through a “19F relaxation switch” phenomenon.
American Journal of Physiology-renal Physiology | 2015
Junjie Chen; Chandu Vemuri; Rohun U. Palekar; Joseph P. Gaut; Matthew J. Goette; Lingzhi Hu; Grace Cui; Huiying Zhang; Samuel A. Wickline
In the extension phase of acute kidney injury, microvascular thrombosis, inflammation, vasoconstriction, and vascular endothelial cell dysfunction promote progressive damage to renal parenchyma after reperfusion. In this study, we hypothesized that direct targeting and pharmaceutical knockdown of activated thrombin at the sites of injury with a selective nanoparticle (NP)-based thrombin inhibitor, PPACK (phenylalanine-proline-arginine-chloromethylketone), would improve kidney reperfusion and protect renal function after transient warm ischemia in rodent models. Saline- or plain NP-treated animals were employed as controls. In vivo 19F magnetic resonance imaging revealed that kidney nonreperfusion was evident within 3 h after global kidney reperfusion at 34 ± 13% area in the saline group and 43 ± 12% area in the plain NP group and substantially reduced to 17 ± 4% (∼50% decrease, P < 0.05) in the PPACK NP pretreatment group. PPACK NP pretreatment prevented an increase in serum creatinine concentration within 24 h after ischemia-reperfusion, reflecting preserved renal function. Histologic analysis illustrated substantially reduced intrarenal thrombin accumulation within 24 h after reperfusion for PPACK NP-treated kidneys (0.11% ± 0.06%) compared with saline-treated kidneys (0.58 ± 0.37%). These results suggest a direct role for thrombin in the pathophysiology of AKI and a nanomedicine-based preventative strategy for improving kidney reperfusion after transient warm ischemia.
Magnetic Resonance in Medicine | 2014
Lingzhi Hu; Junjie Chen; Xiaoxia Yang; Angana Senpan; John S. Allen; Noriko Yanaba; Shelton D. Caruthers; Gregory M. Lanza; Marc R. Hammerman; Samuel A. Wickline
We sought to develop a unique sensor‐reporter approach for functional kidney imaging that employs circulating perfluorocarbon nanoparticles and multinuclear 1H/19F MRI.
Magnetic Resonance in Medicine | 2014
Lingzhi Hu; Junjie Chen; Xiaoxia Yang; Angana Senpan; John S. Allen; Noriko Yanaba; Shelton D. Caruthers; Gregory M. Lanza; Marc R. Hammerman; Samuel A. Wickline
We sought to develop a unique sensor‐reporter approach for functional kidney imaging that employs circulating perfluorocarbon nanoparticles and multinuclear 1H/19F MRI.